RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas Conference

Vogelbaum, MA, Berkey, B, Peereboom, D et al. (2005). RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas . JOURNAL OF CLINICAL ONCOLOGY, 23(16), 119S-119S.

cited authors

  • Vogelbaum, MA; Berkey, B; Peereboom, D; Giannini, C; Suh, J; Brown, P; Blumenthal, D; Biggs, C; Schultz, C; Mehta, M

sustainable development goals

authors

date/time interval

  • May 13, 2005 -

publication date

  • June 1, 2005

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Orlando, FL

Conference

  • 41st Annual Meeting of the American-Society-of-Clinical-Oncology

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 119S

end page

  • 119S

volume

  • 23

issue

  • 16